Predicament of classification: Multisystem small vessel vasculitis with cresentic Glomerulonephritis

Leavitt RY, Fauci AS, Bloch DA, Beat A. Michel MD, et al. The American College of Rheumatology 1990 criteria for the classification of Wegner’s granulomatosis. Arthritis Rheum. 1990; 33: 1101-1107. Ref.: https://goo.gl/Fn5yLe

Liu LJ, Chen M, Yu F, Zhao MH, Wang HY. Evaluation of a new algorithm in classification of systemic vasculitis. Rheumatology (Oxford). 2008; 47: 708-712. Ref.: https://goo.gl/obBh5t

Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013; 65: 1-11. Ref.: https://goo.gl/Ggc7iz

Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, et al. Nomenclature of systemic Vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994; 37: 187-192. Ref.: https://goo.gl/jDjP9X

Watts R, Lane S, Hanslik T, Hauser T, Hellmich B, et al. Development and validation of a consensus methodology for the classification of the ANCA-associated Vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis. 2007; 66: 222-227. Ref.: https://goo.gl/pSNj3E

Hogan SL, Falk RJ, Chin H, Cai J, Jennette CE, et al. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med. 2005; 143: 621-631. Ref.: https://goo.gl/Hk9xrE

Pepper RJ, Salama AD. Classifying and predicting outcomes in ANCA-associated glomerulonephritis. Nephrol Dial Transplant. 2012; 27: 2135-2137. Ref.: https://goo.gl/7KWDLL

Hogan SL, Falk RJ, Nachman PH, Jennette JC. Various forms of life in antineutrophil cytoplasmic antibody-associated vasculitis. Ann Intern Med. 2006; 144: 377-378. Ref.: https://goo.gl/V8yvug

Guillevin L, Durand-Gasselin B, Cevallos R, Gayraud M, Lhote F, et al. Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum. 1999; 42: 421-430. Ref.: https://goo.gl/KWuuTg

Finkielman JD, Lee AS, Hummel AM, Viss MA, Jacob GL, et al. ANCA are detectable in nearly all patients with active severe Wegener’s granulomatosis. Am J Med. 2007; 120: e9-14. Ref.: https://goo.gl/gMgjue

Falk RJ, Jennette JC. ANCA small-vessel vasculitis. J Am Soc Nephrol. 1997; 8: 314-322. Ref.: https://goo.gl/uTVeEB

Hagen EC, Daha MR, Hermans J, Andrassy K, Csernok E, et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int. 1998; 53: 743-753. Ref.: https://goo.gl/ESXGoJ

Savige J, Pollock W, Trevisin M. What do antineutrophil cytoplasmic antibodies (ANCA) tell us?. Best Pract Res Clin Rheumatol. 2005; 19: 263-276. Ref.: https://goo.gl/qQnWxy

Falk RJ, Jennette JC. ANCA disease: where is this field heading?. J Am Soc Nephrol. 2010; 21: 745-752. Ref.: https://goo.gl/9HChy7

Jennette JC, Falk RJ. Small-vessel vasculitis. N Engl J Med. 1997; 337: 1512-1523. Ref.: https://goo.gl/idmovz

Seo P, Stone JH. The antineutrophil cytoplasmic antibody-associated Vasculitides. Am J Med. 2004; 117: 39-50. Ref.: https://goo.gl/s4uRwk

Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med. 1992; 116: 488-498. Ref.: https://goo.gl/p8L8jv

Gomez-Puerta JA, Hernandez-Rodriguez J, Lopez-Soto A, Bosch X. Antineutrophil cytoplasmic antibody-associated Vasculitides and respiratory disease. Chest. 2009; 136: 1101-1111. Ref.: https://goo.gl/4rsyhk

Solans-Laque R, Bosch-Gil J, Canela M, Lorente J, Pallisa E, et al. Clinical features and therapeutic management of subglottic stenosis in patients with Wegener’s granulomatosis. Lupus. 2008; 17: 832-836. Ref.: https://goo.gl/41KErS

Savage CO, Winearls CG, Evans DJ, Rees AJ, Lockwood CM. Microscopic polyarteritis: presentation, pathology and prognosis. Q J Med. 1985; 56: 467-483. Ref.: https://goo.gl/CMyRKb

Cordier JF, Valeyre D, Guillevin L, Loire R, Brechot JM. Pulmonary Wegener’s granulomatosis. A clinical and imaging study of 77 cases. Chest. 1990; 97: 906-912. Ref.: https://goo.gl/TgF5mC

Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener’s granulomatosis; prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med. 1993; 98: 76-85. Ref.: https://goo.gl/tFn9YF

Haas M, Eustace JA. Immune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases. Kidney Int. 2004; 65: 2145-2152. Ref.: https://goo.gl/ntDFys

Neumann I, Regele H, Kain R, Birck R, Meisl FT. Glomerular immune deposits are associated with increased proteinuria in patients with ANCA-associated crescentic nephritis. Nephrol Dial Transplant. 2003; 18: 524-531. Ref.: https://goo.gl/2qCqT7

Eisenberger U, Fakhouri F, Vanhille P, Beaufils H, Mahr A, et al. ANCA-negative pauci-immune renal vasculitis: histology and outcome. Nephrol Dial Transplant. 2005; 20: 1392-1399. Ref.: https://goo.gl/rkTtLu